Phase IIb study of NN1953 in type-2 diabetes mellitus
Latest Information Update: 04 Sep 2015
Price :
$35 *
At a glance
- Drugs Insulin 338 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Sep 2015 New trial record
Latest Information Update: 04 Sep 2015